RNS Number : 5695V
Venteco PLC
30 May 2008
30 May 2008
Venteco plc
Preliminary Results for the year ended 31 December 2007
Venteco plc ('Venteco' or 'the Company'), the UK-based non-toxic pest control provider, announces its financial results for the year ended 31 December 2007, which have been prepared in accordance with International Financial Reporting Standards.
Financial Summary
Operational Summary
-
Successfully integrated the two acquisitions, Silvandersson AB, a leading manufacturer of insect glue traps, and SIK Valiguard AB, the Swedish-based specialist in food industry hygiene and safety certification
Commenting on the results, Stefan Hansson, Chief Executive of the Company, said: '2007 was a transformational year for the Company as it laid the foundations for its long-term growth. Having overcome the challenges of distribution and franchising as well as product reliability, the Company is better placed to drive growth. I look forward to 2008 as a year of increased turnover and improved performance.'
Enquiries:
Venteco plc
|
|
Stefan Hansson, Barry Gibb
|
+44 (0) 207 977 0020
|
Libertas Capital
|
|
Aamir Quraishi, Sandy Jamieson
|
+44 (0) 207 569 9650
|
Corfin Communications
|
|
William Cullum, Clare Perks
|
+44 (0) 207 977 0020
|
Overview
2007 was a transformational year for Venteco. Revenues increased by £4.21m to £4.45m (£0.24m in 2006) reflecting Venteco's increasing penetration, through the two acquisitions, of the non-toxic pest control market globally.
The first half of the year to 30th June was a busy and successful time. Having recognised its market opportunity in international pest control, Venteco successfully incorporated two acquisitions whilst reviewing several new prospects and producing its first ever net profit.
Interest in Cryonite remains high. However, in the second half, the Company experienced distribution and marketing problems, resulting in a much slower than anticipated deployment of the Company's Cryonite technology, and poor weather conditions impacted on the demand for Silvandersson's products. This resulted in a net loss position for Venteco for the full year.
The Board acted quickly, initially by thoroughly reviewing Venteco's business plan and then by addressing all outstanding eventualities that might limit scope to fulfill its true potential. As announced on 20 December 2007, Mats Andersson stepped down as Chairman of the Board and Haresh Kanabar stepped up from non-executive director to become the new Chairman.
Pest control remains a long-term growth market. Indeed, the pace of expansion of the industrialised world suggests that the underlying rate must now be well in excess of the 5% to 10% range generally quoted by industry specialists. Operating in a sector that is widely recognised for its lack of innovation, this opens important and significant opportunities for Venteco.
Operational Review
CTS Technologies
Public and professional interest in Cryonite technology remains very high. However in order to achieve 2007's targeted deployment, the Company needed (i) distribution and franchise arrangements to work in harmony; and (ii) an exceptional level of product reliability. As the year progressed, problems in both of these areas became apparent and unit deployment fell well short of target.
The latter was relatively easy to resolve and newly outsourced manufacturing and assembly arrangements have had the desired effect. In 2008, CTS will be able to accelerate opportunities to engineer out cost while investigating production of other and complementary derivatives.
Resolving the former has been an altogether more complicated exercise. As a result, Venteco's partner, Linde AG, whose projected sales into Europe had fallen significantly short of target, agreed to hand back its marketing responsibilities to CTS, while confirming its surrender of inventories and retained lease portfolio. As a result, costs, and thus the break-even point, will be substantially lowered for CTS, even if based on a highly conservative sales projection for 2008. In the short term, this is balanced by a negative impact on cash flow.
Silvandersson
Venteco's leading provider of non-toxic fly control products reported a strong first half. The experience was not repeated in the second, however, due to exceptional damp and unusually cool weather conditions in its principal European sales territory. Sales for the full year rose by 12% (compared with 26% in the first half) to £4.1m, producing an operating profit of £0.12m.
Although a repeat of such circumstances is not anticipated for 2008, management does recognise that weather patterns are likely to become less predictable. As a result, demand cycles will be less regular and altogether more volatile. Silvandersson's response has been to review its working practices in order to allow greater flexibility in production, reduce working capital and dispose of non-core assets. Silvandersson's geographical sales and product strategy has been revised. Such actions are expected to support good volume growth and mitigate margin pressure that would otherwise be the inevitable result of slowing economic conditions across Europe.
Valiguard
Valiguard performed in-line with expectations for the whole of 2007. Sales rose by 19% £0.37m.This growth is due to increased demand for certifications.
Responding to customer demand, Valiguard expanded its offering to include new certification standards while also extending its services into consultancy and educational products. This, combined with the strengthening of its business development department, is expected to result in further market share gains while also winning higher revenue per assignment.
Early in the New Year, Valiguard was approved for certification to the KRAV standard for organic food. This can be bundled into the company's offering of BRC and ISO 22000 products and so widenening Valiguard's customer appeal.
Financial Review
In 2007, the Company increased its revenues by £4.21m to £4.45m (2006: £0.24m), benefiting from the consolidation of two acquisitions during 2007.
Operating losses rose to £1.72m for the period to December 2007 (2006: £0.45m) including a goodwill write down of £ 0.87m, reflecting a revision of future trading expectations.
Losses before tax amounted to £1.78m (2006: £0.37m)
Cash and cash equivalents fell to £0.94m at the 2007 year end (2006: £2.23m)
Market Opportunity
The two acquisitions of Silvandersson and SIK Valiguard will provide a platform on which the Company will build its innovative approach to non-toxic and environmentally friendly pest control.
Government and industry attitudes now tend toward policies of greater social responsibility, while an ever more 'ecologically-aware' public is becoming increasingly reluctant to use toxins where alternative or 'green' solutions already exist. Venteco's products and technologies provide an alternative treatment and 'green solution' to the problem of pest control. Market opportunities for such a solution are plentiful and can be found in hospitals, food producers, pharmaceutical companies, hotels and restaurants, through to general kitchen locations and the retail market.
Although Cryonite is the Company's core technology, Venteco's business plan is based on the concept of becoming a 'complete solution supplier' to the international non-toxic pest control market. Operating in an exceptionally fragmented business landscape, the Company is able to identify a number of potential 'bolt on' targets that are complementary in terms of geography, product offering, client base and technology.
Outlook
Having stepped up its own marketing, CTS concluded over 50 new unit leases by the end of the first quarter of 2008. New distributors have been appointed in the North America, including an agreement with the national giant, Orkin, together with regional franchises in Canada and on the East Coast. Exceptional interest in the Far East has resulted in appointments in Singapore and Philippines, while similar discussions continue in France, Germany, Spain and Israel. Increased activity in these areas are expected to coincide with the creation of a 'user-exchange', through which 'club letters', training manuals, an information hot-line, marketing information, testimonials etc, should be accessed through a re-vamped web service. CTS will also spearhead a newly focused marketing campaign, whereby its products are trialed by major hotel chains and global food manufacturers and their particular pest control problems addressed through a bespoke, rather than general, service.
The Board believes that in 2008 the Company will start to seize the true market opportunity for Cryonite. Initiatives such as flexible working patterns are underway to insulate the Company from today's less predictable weather patterns which have a direct impact on the pest population and hence the Company's business. Also, the programme of cost elimination that began last year will continue into the current period.
In the shorter term, some of the regions into which the Company sells are facing a period of slowing economic growth. This may result in pricing pressure in more commoditised product areas as well as the need for us to actively hedge exposure to certain international currencies.
However, Venteco is excellently positioned to capture a greater share of the growing non-toxic pest control market. The problems faced in the second half of 2007 have now been addressed. 2008 will see the Company regain momentum, incorporate a wider global distribution network and complete its efficiency programme, resulting in a year of continued growth and improved profitability.
Consolidated Income Statement
for the year ended 31 December 2007
|
|
2007
|
|
2006
|
|
|
£'000
|
|
£'000
|
|
|
|
|
|
Revenue
|
2
|
4,454
|
|
244
|
|
|
|
|
|
Cost of sales
|
|
(2,269)
|
|
(98)
|
|
|
|
|
|
Gross profit
|
|
2,185
|
|
146
|
|
|
|
|
|
Administrative expenses
|
|
(4,393)
|
|
(600)
|
Other gains and losses
|
|
486
|
|
4
|
|
|
|
|
|
Loss from operations
|
|
(1,722)
|
|
(450)
|
|
|
|
|
|
Finance income
|
|
26
|
|
86
|
Finance costs
|
|
(79)
|
|
(1)
|
|
|
|
|
|
Loss before taxation
|
|
(1,775)
|
|
( 365)
|
|
|
|
|
|
Taxation
|
|
45
|
|
-
|
|
|
|
|
|
Loss attributable to equity shareholders
|
|
(1,730)
|
|
( 365)
|
|
|
|
|
|
|
|
|
|
|
Earnings per share
|
3
|
|
|
|
|
|
|
|
|
Basic and fully diluted loss per share
|
|
(9.34p)
|
|
(2.62p)
|
Consolidated Balance Sheet
At 31 December 2007
|
|
2007
|
|
2006
|
Assets
|
|
£'000
|
|
£'000
|
|
|
|
|
|
Non-current assets
|
|
|
|
|
Goodwill
|
|
710
|
|
1,382
|
Other intangible assets
|
|
245
|
|
200
|
Furniture, fittings and equipment
|
|
1,477
|
|
7
|
Deferred tax asset
|
|
-
|
|
25
|
|
|
2,432
|
|
1,614
|
Current assets
|
|
|
|
|
Inventories
|
|
1,288
|
|
2
|
Trade and other receivables
|
|
1,051
|
|
136
|
Cash and cash equivalents
|
|
944
|
|
2,231
|
|
|
3,283
|
|
2,369
|
|
|
|
|
|
Total assets
|
|
5,715
|
|
3,983
|
|
|
|
|
|
Equity and liabilities
|
|
|
|
|
Equity attributable to equity holders of the company
|
|
|
|
|
Called up share capital
|
|
1,852
|
|
1,744
|
Share premium account
|
|
2,634
|
|
2,366
|
Reverse acquisition reserve
|
|
306
|
|
306
|
Currency translation reserve
|
|
154
|
|
9
|
Accumulated losses
|
|
(2,273)
|
|
( 543)
|
|
|
|
|
|
Total equity
|
|
2,673
|
|
3,882
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
Trade payables
|
|
429
|
|
53
|
Tax liabilities
|
|
191
|
|
-
|
Bank loans and overdrafts
|
|
837
|
|
-
|
Other liabilities
|
|
5
|
|
1
|
Accrued expenses and deferred income
|
|
479
|
|
47
|
|
|
1,941
|
|
101
|
|
|
|
|
|
Non-current liabilities
|
|
|
|
|
Bank loans
|
|
941
|
|
-
|
Deferred tax liability
|
|
160
|
|
-
|
|
|
1,101
|
|
-
|
|
|
|
|
|
Total liabilities
|
|
3,042
|
|
101
|
|
|
|
|
|
Total equity and liabilities
|
|
5,715
|
|
3,983
|
|
|
|
|
|
Consolidated Statement of Changes in Equity
for the year ended 31 December 2007
|
|
Share
Capital
|
Share
Premium
Account
|
Reverse
Acquisition
Reserve
|
Currency
Translation
Reserve
|
Accumulated
Losses
|
Total
|
Balance at 1 January 2006
|
596
|
-
|
(149)
|
-
|
(221)
|
226
|
Loss for the period
|
-
|
-
|
-
|
-
|
(365)
|
(365)
|
Exchange rate translation
|
-
|
-
|
-
|
9
|
-
|
9
|
CTS Technologies AG- share issue
|
10
|
-
|
82
|
-
|
-
|
92
|
Acquisition of CTS Technologies AG
|
1,138
|
2,366
|
373
|
-
|
43
|
3,920
|
|
|
|
|
|
|
|
|
Balance at 31 December 2006
|
1,744
|
2,366
|
306
|
9
|
(543)
|
3,882
|
|
|
|
|
|
|
|
|
Loss for the period
|
-
|
-
|
-
|
-
|
(1,730)
|
(1,730)
|
|
|
|
|
|
|
|
|
Exchange rate translation
|
-
|
-
|
-
|
145
|
-
|
145
|
|
|
|
|
|
|
|
|
Share issue-acquisition of Silvanderson
|
108
|
268
|
-
|
-
|
-
|
376
|
|
|
|
|
|
|
|
|
Balance at 31 December 2007
|
1,852
|
2,634
|
306
|
154
|
(2,273)
|
2,673
|
|
|
|
|
|
|
|
|
Consolidated Cash Flow
for the year ended 31 December 2007
|
|
2007
|
|
Restated
2006
|
|
|
£'000
|
|
£'000
|
|
|
|
|
|
Net cash from operating activities
|
5
|
(1,058)
|
|
( 475)
|
|
|
|
|
|
Investing activities
|
|
|
|
|
Purchase of patents and trademarks
|
|
-
|
|
( 47)
|
Acquisition of subsidiary
|
|
(1,624)
|
|
( 428)
|
Interest received
|
|
26
|
|
86
|
Net cash used in investment activities
|
|
(1,598)
|
|
( 389)
|
|
|
|
|
|
Financing activities
|
|
|
|
|
Net proceeds of share issues
|
|
-
|
|
92
|
Net cash inflow arising on acquisition
|
|
133
|
|
2,994
|
New bank loan received
|
|
1,331
|
|
-
|
Repayment of borrowings
|
|
(76)
|
|
-
|
Interest paid
|
|
(79)
|
|
( 1)
|
Net cash from financing activities
|
|
1,309
|
|
3,085
|
|
|
|
|
|
Cash flow for the year
|
|
|
|
|
Net (decrease)/ increase in cash and cash equivalents
|
|
(1,347)
|
|
2,221
|
|
|
|
|
|
Effect of foreign exchange rate changes
|
|
60
|
|
( 1)
|
Cash and cash equivalents at beginning of year
|
|
2,231
|
|
11
|
|
|
|
|
|
Cash and cash equivalents at 31 December 2007
|
|
944
|
|
2,231
|
Basis of preparation
The results have been prepared using accounting policies consistent with those used in the preparation of the statutory accounts. The financial information is derived from the financial statements for the Year ended 31 December 2007, and does not constitute full accounts within the meaning of Section 240 of the Companies Act 1985. The financial statements on which the auditors have given an unqualified report do not contain a statement under Section 237 (2) or (3) of the Companies Act and will be delivered to the Registrar of Companies in due course.
The financial statements have been prepared under the historical cost convention and in accordance with International Financial Reporting Standards.
2. Segmental information
For management purposes, the Group is currently organised as one operating division. The principal activity of the division is the supply of pest control products and services.
Segment information about this activity is as follows:
|
2007
|
2006
|
|
Pest control products and services
|
Total
|
Pest control products and services
|
Restated
Total
|
|
£'000
|
£'000
|
£'000
|
£'000
|
Revenue
External sales
|
4,454
|
4,454
|
244
|
244
|
Total sales
|
4,454
|
4,454
|
244
|
244
|
|
|
|
|
|
Result
|
|
|
|
|
Segment result
|
(301)
|
(301)
|
( 245)
|
( 245)
|
Unallocated corporate expenses
|
|
(1,907)
|
|
( 209)
|
Loss from operations
|
(301)
|
(2,208)
|
( 245)
|
(454)
|
Other gains and losses
|
|
486
|
|
4
|
Finance costs
|
|
(79)
|
|
( 1)
|
Finance income
|
|
26
|
|
86
|
Loss before tax
|
|
(1,775)
|
|
( 365)
|
Taxation
|
|
45
|
|
-
|
Loss after tax
|
|
(1,730)
|
|
( 365)
|
|
|
|
|
|
Other Information
|
|
|
|
|
Tangible asset additions
|
|
2,978
|
|
-
|
Intangible asset additions
|
|
341
|
|
47
|
Depreciation and Amortisation
|
|
1,609
|
|
19
|
|
|
|
|
|
Balance Sheet
|
|
|
|
|
Assets
|
|
|
|
|
Segment assets
|
3,625
|
3,625
|
394
|
394
|
Unallocated corporate assets
|
|
2,090
|
|
3,589
|
Consolidated total assets
|
3,625
|
5,715
|
394
|
3,983
|
Liabilities
|
|
|
|
|
Segment liabilities
|
1,506
|
1,506
|
31
|
31
|
Unallocated corporate liabilities
|
|
1,536
|
|
70
|
Consolidated total liabilities
|
1,506
|
3,042
|
31
|
101
|
3. Earnings per share
|
2007
|
|
2006
|
|
£'000
|
|
£'000
|
Loss
|
|
|
|
Loss for the purpose of basic and diluted loss per share
|
(1,730)
|
|
( 365)
|
|
|
|
|
Number of shares
|
|
|
|
Weighted average number of ordinary shares in issue during
the period
|
18,515,244
|
|
13,908,921
|
|
|
|
|
Basic and fully diluted loss per share
|
(9.34p)
|
|
(2.62p)
|
The denominators for the purposes of calculating both basic and diluted earnings per share in 2006 have been adjusted for the share division that took place in 2007.
4. Acquisition of a subsidiary
Acquisition of Silvandersson
On 22 January 2007, Venteco Plc acquired all of the issued and outstanding share capital of Silvandersson Sweden AB a leading manufacturer of insect glue traps.
Under the terms of the agreement, Venteco paid an initial consideration, at completion, of £1.61m of which £1.23m was paid in cash and the balance was satisfied by the issue of 21,445,906 new Venteco shares.
The balance of the consideration, being up to a further £81,000 will be payable in cash and is dependent on certain profit targets being met during 2008. Profit targets were not met in 2007.
The cash element of the consideration is fully debt financed.
Acquisition of Silvandersson
The net assets of Silvandersson at the date of acquisition are estimated to be £2.3m as set out below.
Fair value of net assets of Silvandersson at date of acquisition:
|
Book Value
£'000
|
Fair value adjustments
£'000
|
Fair value
£'000
|
Property, plant and equipment
|
829
|
655
|
1,484
|
Patent and trade marks
|
35
|
-
|
35
|
Research and development
|
-
|
93
|
93
|
Customer lists
|
-
|
135
|
135
|
Inventories
|
1,021
|
-
|
1,021
|
Trade and other receivables
|
563
|
197
|
760
|
Cash & cash equivalents
|
66
|
-
|
66
|
Long term loan
|
(329)
|
-
|
(329)
|
Deferred tax
|
(178)
|
(37)
|
(215)
|
Trade payables and other current liabilities
|
(543)
|
(171)
|
(714)
|
Net assets of Silvandersson
|
1,464
|
872
|
2,336
|
Goodwill and intangibles
|
|
|
(498)
|
Total consideration including estimated acquisition costs
|
|
|
1,838
|
|
|
|
|
Satisfied by:
|
|
|
|
Cash
|
|
|
1,231
|
Shares
|
|
|
375
|
Deferred contingent consideration
|
|
|
81
|
Acquisition costs
|
|
|
151
|
|
|
|
1,838
|
The carrying amount of the assets acquired is the same as their fair value.
Acquisition of SIK Valiguard
On 2 February 2007, Venteco Plc acquired the entire share capital of SIK Valiguard AB, the Swedish-based specialist in food industry hygiene and safety certification from SIK, the Swedish Institute of Food and Biotechnology.
Venteco paid an initial consideration £0.26m. Further consideration up to a maximum of £0.18m was payable dependent on certain profit targets being met for 2007. These profit targets were not met.
The net assets of Valiguard at the date of acquisition are estimated to be £43,000 as set out below.
Fair value of net assets of SIK Valiguard at date of acquisition:
|
£'000
|
Property, plant and equipment
|
2
|
Trade and other receivables
|
78
|
Cash at bank
|
67
|
Trade payables and other current liabilities
|
(104)
|
Net assets of Valiguard
|
43
|
Goodwill
|
199
|
Total consideration including estimated acquisition costs
|
242
|
|
|
Satisfied by:
|
|
Cash
|
236
|
Acquisition costs
|
6
|
|
242
|
The carrying amount of the assets acquired is the same as their fair value.
5. Cash flow statement
Net cash from operating activities
|
Group
|
|
|
2007
|
|
Restated*
2006
|
|
|
£'000
|
|
£'000
|
|
|
|
|
|
|
Loss after tax
|
(1,730)
|
|
( 365)
|
|
Tax
|
(45)
|
|
|
|
Write up of negative goodwill
|
(498)
|
|
|
|
Interest received
|
(26)
|
|
|
|
Interest paid
|
79
|
|
(85)
|
|
Investment write down
|
871
|
|
|
|
Adjustment for depreciation and amortisation
|
448
|
|
19
|
|
Operating cash flows before movements in working capital
|
(901)
|
|
( 431)
|
|
(Increase)/decrease in inventories
|
(265)
|
|
1
|
|
Increase in receivables
|
(77)
|
|
( 106)
|
|
Increase in payables
|
185
|
|
61
|
|
Cash used by operations
|
(1,058)
|
|
( 475)
|
|
*Restated from Loss after tax (prior year Loss from operations)
The Annual Report will be posted shortly to all shareholders. Additional copies are available from
2nd Floor, 50 Gresham Street, London EC2V 7AY.
This information is provided by RNS
The company news service from the London Stock Exchange
END
FR IFFLIEDIAFIT